The trademark ENDOLEX was filed by SUN WAVE PHARMA INTERNATIONAL LIMITED, a corporation established under the laws of the Republic of Cyprus (the "Applicant"). The application was published for oppositions on March 14, 2022, and received undefined oppositions.
Opposition Proceedings
There are undefined Oppositions claimed against trademark.
The first opposition filed on June 12, 2022 by LEK farmacevtska druzba d.d. on Likelihood of confusion. the opponent was represented by Nordemann Czychowski & Partner Rechtsanwältinnen und Rechtsanwälte mbB and its proceedings were handled in English The second opposition filed on May 29, 2022 by KERN PHARMA, S.L. on (a) Identity of marks and Goods and Services, (b) Likelihood of confusion. the opponent was represented by SUGRAÑES, S.L.P. and its proceedings were handled in English
The application was filed in Romanian, and Romanian was also language of all opposition proceedings (English was selected as the second language).
The Opposition with reference B 003172730 was rejected according to Article 8(1)(b) EUTMR with decision issued on October 30, 2023 by the EUIPO. The Appeal with reference B R2457/2023-4 was Trade mark application allowed according to Article 8(1)(b) EUTMR with decision issued on December 1, 2024 by the EUIPO.
Goods And Services
The mark was filed in class 5 with following description of goods:
Food supplements
Dietary supplements for humans
Dietary and nutritional supplements
Nutritional supplements
Medicated food supplements
Food supplements in liquid form
Protein dietary supplements
Anti-oxidant supplements
Dietary supplements in powder form
Liquid nutritional supplements
Prebiotic supplements
Probiotic supplements
Vitamin and mineral supplements
Vitamins and vitamin preparations
Dietary supplemental drinks
Dietetic foods adapted for medical purposes
Dietetic food preparations adapted for medical use